Home > Boards > US OTC > Cannabis >

Nexien BioPharma Inc. (NXEN)

NXEN RSS Feed
Add NXEN Price Alert      Hide Sticky   Hide Intro
Moderator: The Rooster, LittleBambi, Farmer7, JMMatthews, GOIN/Green
Search This Board: 
Last Post: 3/20/2019 9:30:13 AM - Followers: 70 - Board type: Free - Posts Today: 3

Intiva BioPharma Inc. Announces Name Change to Nexien BioPharma Inc.

DENVER, CO / ACCESSWIRE / October 1, 2018 / Intiva BioPharma Inc. (OTCQB: NTVA) (the "Company") announces that the Company has changed its corporate name to Nexien BioPharma Inc. ("Nexien").

The new corporate name, Nexien BioPharma, was inspired by the Company's mission of becoming a global leader in the further evolution of cannabinoid science and the development of Food and Drug Administration ("FDA") compliant pharmaceuticals based on specific cannabinoid molecules.

Stock Symbol = NXEN NTVA 

https://nexienbiopharma.com/team


https://nexienbiopharma.com/


Welcome to Nexien BioPharma Inc

Nexien BioPharma is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration ("FDA") protocols, for a number of pharmaceutical formulations that include cannabinoids.

BioPharma’s drug development strategy consists of:

1. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations;

2. Conducting “freedom to operate” investigations on these conditions;

3. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents;

4. Identifying the regulatory pathway with the U.S. Food and Drug Administration (FDA); and

5. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to investigate and ultimately obtain approval for the particular product(s).

Nexien BioPharma is currently researching and developing proprietary pharmaceutical formulations consisting of different cannabinoids and terpenes.

Due to the legal and regulatory challenges in researching cannabinoids derived from the cannabis plant in the United States, Nexien BioPharma is initially focused on developing drugs utilizing synthetic cannabinoids. If the Company intends to proceed in researching pharmaceuticals derived from the cannabis plant, it will proceed with the research and trials in a country where the research is legal, such as Israel, and not in the U.S.

 
 
The Company is researching and developing drug and cannabinoid molecules
for various medical conditions and diseases.  
ArcView Market Research estimates that
America's pharmaceutical cannabis sector could reach over $23 billion by 2020. 
  

 

Recent Nexien BioPharma Inc. SEC Filings

https://www.otcmarkets.com/stock/NXEN/disclosure

`
Shares O/S ~ 55 Million 

Recent News - https://www.otcmarkets.com/stock/NXEN/news
Nexien BioPharma Releases Letter to Shareholders Announcing 2019 Plans, 2018 Activities, and Work to Come From Acquisitions Press Release | 12/06/2018
Nexien BioPharma And Ivy League University Medical School Collaborate On Pre-Clinical Cannabinoid Studies Press Release | 11/28/2018
Uptick Newswire's Stock Day Podcast Interviews Nexien BioPharma CEO, Alex Wasyl, to Discuss the Acquisition of CRX Bio Holdings and The Company’s Future in The Pharmaceutical Space Press Release | 11/26/2018
Nexien BioPharma Advances in Clinical Use of a Cannabinoid-Based Formulation for the Treatment of Myotonic Dystrophies and Myotonia Press Release | 11/06/2018
Nexien BioPharma Acquires Princeton-Based CRx Bio and Announces Additions to Senior Management Press Release | 10/30/2018

INTIVA BioPharma Inc. Announces Name Change to Nexien BioPharma Inc. Press Release | 10/01/2018

_______________________________________________________________________

Investor Relations: 303.495.7583

Pharma Research & Development:800.815.2071

info@nexienbiopharma.com
3773 South Cherry Creek Drive Ste 575
Denver, Colorado


Like & Follow Nexien Biopharma on Social Media

Facebook

https://www.facebook.com/NexienBiopharma/

Twitter
https://twitter.com/NexienBiopharma



   
NXEN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NXEN News: Current Report Filing (8-k) 03/08/2019 01:33:00 PM
NXEN News: Information Statement - All Other (definitive) (def 14c) 03/08/2019 09:37:17 AM
NXEN News: Current Report Filing (8-k) 03/05/2019 08:57:06 AM
NXEN News: Current Report Filing (8-k) 02/26/2019 08:56:51 AM
NXEN News: Quarterly Report (10-q) 02/14/2019 06:41:52 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1724  Sticky Note Effective October 19, 2018, the common stock of JMMatthews 10/19/18 10:13:29 AM
#3158   I'll gladly wait and add when funds are available. Gonfishun 03/20/19 09:30:12 AM
#3157   They just updated their timeline on the website. Ortiz26 03/20/19 08:34:20 AM
#3156   12-18 months nanook2 03/20/19 12:59:13 AM
#3155   What is your time line on this? LittleBambi 03/19/19 11:06:27 PM
#3154   The irony is.. Renegades17 03/19/19 10:54:14 AM
#3153   This is more about the company's lack of Gtc_123 03/19/19 10:14:01 AM
#3152   Lmao watch and learn. I’ve been trading penny Ortiz26 03/14/19 03:09:33 PM
#3151   Well I got all out at .15 avg. Chenteddybear 03/14/19 03:02:57 PM
#3150   And people like you who dump into the Ortiz26 03/14/19 03:00:19 PM
#3149   It’s gonna go lower because this is OTC Chenteddybear 03/14/19 02:20:39 PM
#3148   Keep selling. nanook2 03/13/19 10:59:51 PM
#3147   Yea with bid wacks, genius. Someone trying to Ortiz26 03/13/19 10:24:00 AM
#3146   A flush down coming..... .10 getting tested Chenteddybear 03/13/19 10:14:41 AM
#3145   Another new 52 week high today. .10 Chenteddybear 03/13/19 01:38:53 AM
#3144   I’m sitting on the bid and have been. nanook2 03/13/19 01:24:52 AM
#3143   This will erupt by summer imo. Obviously lots Gtc_123 03/12/19 04:06:50 PM
#3142   Lmao the bid wacking and idiots selling for Ortiz26 03/12/19 12:29:16 PM
#3141   Short squeeze coming! Bid keeps growing at Denver3381 03/12/19 10:22:09 AM
#3140   MM bullshit 100 share bid whacks surfgreen 03/11/19 12:44:26 PM
#3139   Very stacked bid Denver3381 03/11/19 12:20:49 PM
#3138   You’re something special lil teddy bear, especially in Ortiz26 03/11/19 12:04:33 PM
#3137   52 week low printed today. .10 Chenteddybear 03/11/19 12:03:25 PM
#3136   Broken stock Renegades17 03/11/19 11:30:56 AM
#3135   Nice! $_$ Chenteddybear 03/10/19 11:46:22 AM
#3133   We will be back over $.50 soon here. BiotechTim 03/10/19 11:02:04 AM
#3131   Capital raise Renegades17 03/09/19 05:32:07 PM
#3130   It’s right there on their site. Ortiz26 03/09/19 03:05:13 PM
#3129   I noticed that as well last night. Very Ortiz26 03/09/19 03:04:48 PM
#3128   8-k was issued late yesterday. Farmer7 03/09/19 02:39:29 PM
#3127   Link? I haven't seen a presentation. What are Renegades17 03/09/19 02:25:32 PM
#3126   That’s a pretty professionally done investor presentation they Farmer7 03/09/19 02:11:07 PM
#3125   Yeah I agree with you unfortunately. Disappointing here JMMatthews 03/08/19 01:12:08 PM
#3124   Lol look who’s back the person who buys Ortiz26 03/08/19 07:44:09 AM
#3123   no one is buying cause , this company soccer.mom23 03/08/19 06:32:55 AM
#3122   No one is buying. Everyone is waiting at Chenteddybear 03/08/19 02:10:57 AM
#3121   .107 new low today.....will see below .10 soon. Chenteddybear 03/08/19 02:08:20 AM
#3120   Therein lies the problem Renegades17 03/06/19 08:16:08 AM
#3119   Just needs volume. When it comes it will nanook2 03/05/19 05:32:41 PM
#3118   Not a comment on the company Renegades17 03/05/19 12:48:00 PM
#3117   No of these idiot bid dumpers will matter surfgreen 03/05/19 12:20:56 PM
#3116   I bought another 35k shares today. I’m here nanook2 03/05/19 12:20:45 PM
#3115   My guess is any idiot, people like that Ortiz26 03/05/19 11:43:37 AM
#3114   Apparently lots of bad selling too Renegades17 03/05/19 11:30:56 AM
#3113   Agreed. Lot of good buying today too, see Ortiz26 03/05/19 10:37:59 AM
#3112   It was good news Renegades17 03/05/19 10:35:15 AM
#3111   Nice News today: DENVER--(BUSINESS WIRE)--Nexien BioPharma, Inc. (“Nexien” or Ortiz26 03/05/19 10:05:27 AM
#3110   Nexien BioPharma Announces Acceptance of Patent Application No. GOIN/Green 03/05/19 09:19:46 AM
#3109   The attached article doesnt mention NXEN, or did MrTrader129 03/05/19 09:08:04 AM
#3108   Great Raising capital at pennies on the dollar. Renegades17 03/05/19 08:02:09 AM
#3107   Should be hearing about the capital raise shortly. surfgreen 03/04/19 12:33:42 PM
PostSubject